Healthcare Simulation Market - Global Forecast To 2030
商品番号 : SMB-6102
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 364 |
| 図表数 | 379 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、ヘルスケアシミュレーション市場を分析しています。製品・サービス、テクノロジー、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、主要プレーヤーの競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても解説しています。
The global healthcare simulation market is projected to reach USD 7.23 billion by 2030 from USD 3.5 billion in 2025, at a CAGR of 15.6%. Key drivers of the healthcare simulation market include the global shift toward competency-based medical education (CBME), increasing emphasis on patient safety, and rapid technological advancements such as AI-powered simulators and VR/AR-based platforms. The growing need for specialty-specific training and remote learning solutions further supports market growth. However, major restraints include the high capital and operational costs associated with simulation infrastructure and limited accessibility in low-resource settings. Additionally, the lack of standardization across simulation practices poses challenges in ensuring consistent training quality.
世界のヘルスケアシミュレーション市場は、2025年の35億米ドルから2030年には72億3000万米ドルに達し、年平均成長率（CAGR）15.6%で成長すると予測されています。ヘルスケア・シミュレーション市場を牽引する主な要因としては、コンピテンシーに基づく医療教育（CBME）への世界的なシフト、患者安全への重視の高まり、AI搭載シミュレーターやVR/ARベースのプラットフォームといった急速な技術進歩などが挙げられます。専門分野に特化したトレーニングや遠隔学習ソリューションへの需要の高まりも、市場の成長を支えています。しかしながら、シミュレーション・インフラに関連する高額な設備投資と運用コスト、そしてリソースが限られた環境でのアクセスの制限などが、市場の成長を阻む大きな要因となっています。さらに、シミュレーション手法の標準化が不十分であることも、トレーニング品質の一貫性確保に課題をもたらしています。
“Web-based simulation segment to witness highest CAGR during forecast period”
Based on the product & service segment, the healthcare simulation market is classified into healthcare simulation anatomical models, healthcare simulation software, web-based simulation, and healthcare simulation training services. Among these, web-based simulation is expected to grow the fastest during the forecast period due to its scalability, flexibility, and cost-efficiency, qualities ideal for academic and healthcare settings. Its adoption has accelerated with the global shift to remote and hybrid learning models, especially post-COVID-19. Unlike hardware-based tools, web-based platforms require minimal infrastructure, making them suitable for resource-constrained environments. These platforms also enable real-time performance tracking, customizable scenarios, and multi-user collaboration, enhancing training outcomes. Furthermore, the integration of cloud computing, AI, and data analytics enables personalized learning and robust assessment. Solutions such as Laerdal’s vSim, CAE Healthcare’s LearningSpace, and Oxford Medical Simulation exemplify the global momentum in this space. This trend reduces dependence on physical labs while expanding access, fueling the segment’s rapid growth.
“Procedural rehearsal technology held largest share of healthcare simulation market in 2024”
The procedural rehearsal technology segment accounted for the largest share of the healthcare simulation market in 2024 because it directly addresses the critical need for hands-on practice for complex medical procedures. This technology enables clinicians and surgeons to rehearse specific surgeries or interventions on highly realistic models, often patient-specific, improving precision and reducing errors during actual procedures. Its widespread adoption is driven by increasing demand for minimally invasive surgeries, growing emphasis on reducing surgical complications, and rising investments in advanced imaging and 3D modeling technologies. Procedural rehearsal technology bridges the gap between theoretical knowledge and real-world application, making it indispensable in medical training and preoperative planning.
“Asia Pacific region to exhibit significant CAGR from 2025 to 2030”
The Asia Pacific region is projected to record the highest CAGR in the global healthcare simulation market during the forecast period. This growth is fueled by a rise in surgical procedures, increasing the need for procedural rehearsal tools, anatomical models, and high-fidelity simulators to ensure safe and effective clinical training. Countries such as China, India, and those in Southeast Asia are investing heavily in healthcare infrastructure and upgrading medical education through simulation technologies. Expansion in this high-potential, underpenetrated market is also supported by greater government funding, global partnerships, and the growing entry of international simulation providers. For example, in April 2022, the Delhi Academy of Medical Sciences (DAMS) launched a simulation-based education facility, allowing medical students to safely practice clinical procedures without risk to real patients.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.
The breakdown of primary participants is as mentioned below:
- By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation – C-level Executives: 42%, Directors: 31%, and Others: 27%
- By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, and Latin America: 5%
Note: Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
Key Players in Healthcare Simulation Market
The key players functioning in the healthcare simulation market include CAE Inc. (Canada), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Kyoto Kagaku (Japan), Limbs & Things (UK), Mentice AB (Sweden), Simulab Corporation (US), Simulaids (US), Intelligent Ultrasound Group PLC (UK), Operative Experience Inc. (UK), Surgical Science Sweden AB (Sweden), Cardionics Inc. (US), VirtaMed AG (Zurich), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), TruCorp Ltd. (Ireland), Simendo B.V. (Netherlands), Haag-Streit Simulation GmbH (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), and Inovus Medical (UK).
Research Coverage:
The report analyzes the healthcare simulation market. It aims to estimate the market size and future growth potential of various market segments based on product & service, technology, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the market’s pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their positions in the market.
This report provides insights on:
Analysis of key drivers: (rising focus on patient safety, rising shift toward competency-based medical education (CBME)), restraints (high setup and operational costs, limited access in low-resource settings), opportunities (growing demand for web-based and remote simulation products and services, rising use of specialty-specific simulation techniques by healthcare professionals), and challenges (lack of standardization in training protocols, limited emotional realism in some tools) influencing the growth of the healthcare simulation market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the healthcare simulation market
- Market Development: Comprehensive information on the lucrative emerging markets, products & services, technologies, end users, and regions
- Market Diversification: Exhaustive information about the product portfolios, untapped geographies, recent developments, and investments in the healthcare simulation market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare simulation market such as CAE Inc. (Canada), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Kyoto Kagaku (Japan), Limbs & Things (UK), Mentice AB (Sweden), Simulab Corporation (US), and Simulaids (US).
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 STUDY SCOPE 30
1.2.2 INCLUSIONS AND EXCLUSIONS 31
1.2.3 YEARS CONSIDERED 31
1.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH APPROACH 34
2.1.1 SECONDARY RESEARCH 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Insights from primary experts 38
2.2 MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
2.4 MARKET SHARE ESTIMATION 46
2.5 RESEARCH ASSUMPTIONS 46
2.6 RESEARCH LIMITATIONS 47
2.6.1 METHODOLOGY-RELATED LIMITATIONS 47
2.6.2 SCOPE-RELATED LIMITATIONS 47
2.7 RISK ASSESSMENT 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 52
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE SIMULATION MARKET 52
4.2 HEALTHCARE SIMULATION MARKET IN ASIA PACIFIC, BY PRODUCT & SERVICE AND COUNTRY 53
4.3 HEALTHCARE SIMULATION MARKET, BY GEOGRAPHY 54
4.4 HEALTHCARE SIMULATION MARKET, BY REGION 55
4.5 HEALTHCARE SIMULATION MARKET: EMERGING VS. DEVELOPED ECONOMIES 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
5.3 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.3.1 DRIVERS 57
5.3.1.1 Rising demand for realistic and risk-free training environments in medical education 57
5.3.1.2 Rapid technological advancements in medical education 58
5.3.1.3 Surging demand for minimally invasive treatments 58
5.3.1.4 Increasing focus on patient safety 59
5.3.1.5 Growing adoption of AI-driven VR platforms to improve clinical decision-making 60
5.3.2 RESTRAINTS 60
5.3.2.1 Limited availability of funds to establish simulation training centers 60
5.3.2.2 Poorly designed medical simulators 61
5.3.3 OPPORTUNITIES 61
5.3.3.1 Widening workforce gaps creating demand for simulation-based training solutions 61
5.3.3.2 Growing awareness about simulation training in emerging economies 62
5.3.4 CHALLENGES 62
5.3.4.1 High cost of simulators 62
5.3.4.2 Operational challenges 63
5.4 INDUSTRY TRENDS 63
5.4.1 USE OF VIRTUAL REALITY AND AUGMENTED REALITY IN HEALTHCARE SIMULATION 63
5.4.2 ADVANCEMENTS IN HIGH-FIDELITY TECHNOLOGY 64
5.4.3 ADOPTION OF MULTIMODAL APPROACH DURING SIMULATOR DEVELOPMENT 64
5.4.4 UTILIZATION OF AI- AND ML-BASED SOFTWARE IN SURGICAL PROCEDURES 65
5.4.5 INCLINATION TOWARD HEALTHCARE INFORMATION TECHNOLOGY/ELECTRONIC MEDICAL RECORDS 65
5.5 TECHNOLOGY ANALYSIS 66
5.5.1 KEY TECHNOLOGIES 66
5.5.2 ADJACENT TECHNOLOGIES 67
5.5.3 ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY 67
5.6 ECOSYSTEM ANALYSIS 68
5.7 VALUE CHAIN ANALYSIS 69
5.8 PORTER’S FIVE FORCES ANALYSIS 70
5.8.1 THREAT OF NEW ENTRANTS 70
5.8.2 THREAT OF SUBSTITUTES 71
5.8.3 BARGAINING POWER OF SUPPLIERS 71
5.8.4 BARGAINING POWER OF BUYERS 71
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.9 PATENT ANALYSIS 72
5.9.1 PATENT PUBLICATION TRENDS IN HEALTHCARE SIMULATION MARKET 72
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 72
5.9.3 LIST OF MAJOR PATENTS 74
5.10 REGULATORY LANDSCAPE 76
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.10.2 GLOBAL REGULATORY STANDARDS 78
5.10.3 HEALTHCARE SIMULATION PRODUCTS REQUIRING PREMARKET APPROVALS FROM REGULATORY BODIES 79
5.10.3.1 North America 79
5.10.3.1.1 US 79
5.10.3.1.2 Canada 80
5.10.3.2 Europe 80
5.10.3.3 Asia Pacific 80
5.10.3.3.1 Japan 80
5.10.3.3.2 China 81
5.10.3.3.3 India 81
5.10.4 INTEROPERABILITY STANDARDS 82
5.11 PRICING ANALYSIS 85
5.11.1 INDICATIVE PRICE OF HEALTHCARE SIMULATION PRODUCTS, BY KEY PLAYERS 2024 85
5.11.2 INDICATIVE PRICE OF HEALTHCARE SIMULATION DEVICES, BY REGION 2024 86
5.12 HEALTHCARE SIMULATION MARKET: INVESTMENT LANDSCAPE 86
5.13 KEY CONFERENCES AND EVENTS, 2025–2026 87
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 88
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
5.15.2 BUYING CRITERIA 90
5.16 CASE STUDY ANALYSIS 91
5.16.1 CASE STUDY 1: ENHANCING CLINICAL READINESS: NORTHUMBRIA UNIVERSITY’S SCALABLE SIMULATION PROGRAM IN PARTNERSHIP WITH OMB 91
5.16.2 CASE STUDY 2: OPTIMIZING PATIENT FLOW AND INFRASTRUCTURE: MEMORIAL HEALTH SYSTEM’S SIMULATION-DRIVEN EFFICIENCY GAINS WITH SIMUL8 92
5.17 UNMET NEEDS IN HEALTHCARE SIMULATION MARKET 92
5.17.1 EXPECTATIONS OF END USERS 93
5.18 IMPACT OF 2025 US TARIFF—OVERVIEW 94
5.18.1 INTRODUCTION 94
5.19 KEY TARIFF RATES 95
5.20 PRICE IMPACT ANALYSIS 96
5.21 IMPACT ON COUNTRIES/REGIONS 96
5.21.1 US 96
5.21.2 EUROPE 96
5.21.3 ASIA PACIFIC 97
5.22 IMPACT ON END USERS 97
6 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE 99
6.1 INTRODUCTION 100
6.2 HEALTHCARE SIMULATION ANATOMICAL MODELS 100
6.2.1 PATIENT SIMULATORS 102
6.2.1.1 By type 105
6.2.1.1.1 High-fidelity simulators 105
6.2.1.1.1.1 Growing adoption of high-fidelity simulators in educational training to drive growth 105
6.2.1.1.2 Medium-fidelity simulators 106
6.2.1.1.2.1 Cost benefits of medium-fidelity simulation to drive demand 106
6.2.1.1.3 Low-fidelity simulators 108
6.2.1.1.3.1 Budgetary constraints and ease of use to drive demand 108
6.2.1.2 By application 110
6.2.1.2.1 Laparoscopic surgical simulators 110
6.2.1.2.1.1 Increasing prevalence of minimally invasive surgeries to drive growth 110
6.2.1.2.2 Gynecology simulators 111
6.2.1.2.2.1 Increasing incidence of fibroids and polyps in women to drive demand 111
6.2.1.2.3 Cardiovascular simulators 111
6.2.1.2.3.1 Increasing prevalence of diabetes to boost demand 111
6.2.1.2.4 Orthopedic surgical simulators 112
6.2.1.2.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 112
6.2.1.2.5 Spine surgical simulators 113
6.2.1.2.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 113
6.2.1.2.6 Endovascular simulators 114
6.2.1.2.6.1 Reduced mortality rates associated with endovascular simulators to boost demand 114
6.2.1.2.7 Other applications in patient simulators 115
6.2.2 TASK TRAINERS 116
6.2.2.1 Inability to imitate emotional attributes of patients to restrain growth 116
6.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 118
6.2.3.1 Laparoscopic surgical simulators 119
6.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth 119
6.2.3.2 Gynecology simulators 120
6.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators 120
6.2.3.3 Cardiovascular simulators 122
6.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand 122
6.2.3.4 Orthopedic surgical simulators 123
6.2.3.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand 123
6.2.3.5 Spine surgical simulators 124
6.2.3.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 124
6.2.3.6 Endovascular simulators 126
6.2.3.6.1 Ability to reduce mortality rates to drive demand for endovascular simulators 126
6.2.3.7 Other surgical simulators 127
6.2.4 ULTRASOUND SIMULATORS 128
6.2.4.1 Inferior quality images due to low dynamics and spatial resolution to restrain growth 128
6.2.5 DENTAL SIMULATORS 129
6.2.5.1 Expanding dental tourism industry to drive growth 129
6.2.6 EYE SIMULATORS 130
6.2.6.1 Increasing incidence of eye disorders to drive growth 130
6.3 WEB-BASED SIMULATION 132
6.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF WEB-BASED SIMULATION 132
6.4 HEALTHCARE SIMULATION SOFTWARE 133
6.4.1 ABILITY TO REDUCE OVERALL SURGICAL PROCESS TRAINING TIME TO DRIVE ADOPTION 133
6.5 HEALTHCARE SIMULATION TRAINING SERVICES 134
6.5.1 VENDOR-BASED TRAINING 135
6.5.1.1 High focus on patient safety to drive demand 135
6.5.2 EDUCATIONAL SOCIETIES 136
6.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth 136
6.5.3 CUSTOM CONSULTING SERVICES 137
6.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth 137
7 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY 139
7.1 INTRODUCTION 140
7.2 VIRTUAL PATIENT SIMULATION 140
7.2.1 INCREASING FOCUS ON AUGMENTED REALITY/VIRTUAL REALITY TO DRIVE MARKET 140
7.3 3D PRINTING 141
7.3.1 INCREASING ADOPTION IN MEDICAL TRAINING TO DRIVE MARKET 141
7.4 PROCEDURAL REHEARSAL TECHNOLOGY 142
7.4.1 NEED FOR ADVANCING SURGICAL SKILLS WITH REHEARSAL TECH TO FUEL MARKET GROWTH 142
8 HEALTHCARE SIMULATION MARKET, BY END USER 144
8.1 INTRODUCTION 145
8.2 ACADEMIC INSTITUTES 145
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND 145
8.3 HOSPITALS 146
8.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND 146
8.4 MILITARY ORGANIZATIONS 147
8.4.1 EXPLORATION OF NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND 147
8.5 OTHER END USERS 148
9 HEALTHCARE SIMULATION MARKET, BY REGION 150
9.1 INTRODUCTION 151
9.2 NORTH AMERICA 151
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 157
9.2.2 US 157
9.2.2.1 Increasing demand for virtual tutors and high healthcare spending to boost growth 157
9.2.3 CANADA 161
9.2.3.1 Increasing funding and surgical capabilities to drive growth 161
9.3 EUROPE 165
9.3.1 EUROPE: MACROECONOMIC OUTLOOK 170
9.3.2 UK 170
9.3.2.1 Rising number of healthcare simulation centers and hospitals to drive growth 170
9.3.3 FRANCE 174
9.3.3.1 Growing focus on use of innovative methods in medical training to drive growth 174
9.3.4 GERMANY 178
9.3.4.1 High healthcare spending to drive market growth 178
9.3.5 ITALY 182
9.3.5.1 Shortage of trained healthcare personnel to drive growth 182
9.3.6 SPAIN 186
9.3.6.1 Increasing number of surgical procedures to boost growth 186
9.3.7 REST OF EUROPE 190
9.4 ASIA PACIFIC 194
9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 200
9.4.2 JAPAN 200
9.4.2.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth 200
9.4.3 CHINA 204
9.4.3.1 Increasing demand for trained medical professionals to drive growth 204
9.4.4 INDIA 208
9.4.4.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth 208
9.4.5 REST OF ASIA PACIFIC 212
9.5 LATIN AMERICA 216
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 220
9.5.2 BRAZIL 220
9.5.2.1 High incidence of chronic diseases to drive market 220
9.5.3 MEXICO 224
9.5.3.1 Disruptive technologies and public-private partnerships to boost growth 224
9.5.4 REST OF LATIN AMERICA 228
9.6 MIDDLE EAST & AFRICA 231
9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 236
9.6.2 GCC 236
9.6.2.1 Focus on enhancing patient care to drive market 236
9.6.3 REST OF MIDDLE EAST & AFRICA 240
10 COMPETITIVE LANDSCAPE 244
10.1 OVERVIEW 244
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 244
10.3 REVENUE ANALYSIS, 2020–2024 247
10.4 MARKET SHARE ANALYSIS, 2024 248
10.5 MARKET RANKING ANALYSIS, 2024 249
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 250
10.6.1 STARS 250
10.6.2 EMERGING LEADERS 251
10.6.3 PERVASIVE PLAYERS 251
10.6.4 PARTICIPANTS 251
10.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 253
10.6.5.1 Company footprint 253
10.6.5.2 Region footprint 254
10.6.5.3 Product & service footprint 255
10.6.5.4 End user footprint 256
10.6.5.5 Technology footprint 257
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 258
10.7.1 PROGRESSIVE COMPANIES 258
10.7.2 RESPONSIVE COMPANIES 258
10.7.3 DYNAMIC COMPANIES 258
10.7.4 STARTING BLOCKS 258
10.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 260
10.7.5.1 Detailed list of key startups/SMEs 260
10.7.5.2 Competitive benchmarking of key startups/SMEs 261
10.8 BRAND/SOFTWARE COMPARISON 262
10.9 COMPETITIVE SCENARIO 263
10.9.1 PRODUCT LAUNCHES/ENHANCEMENTS 263
10.9.2 PRODUCT LAUNCHES/ENHANCEMENTS 263
10.9.3 DEALS 264
10.9.4 OTHER DEVELOPMENTS 265
11 COMPANY PROFILES 266
11.1 KEY PLAYERS 266
11.1.1 SURGICAL SCIENCE SWEDEN AB 266
11.1.1.1 Business overview 266
11.1.1.2 Products offered 267
11.1.1.3 Recent developments 268
11.1.1.3.1 Deals 268
11.1.1.4 MnM view 269
11.1.1.4.1 Key strengths 269
11.1.1.4.2 Strategic choices 269
11.1.1.4.3 Weaknesses and competitive threats 269
11.1.2 LAERDAL MEDICAL 270
11.1.2.1 Business overview 270
11.1.2.2 Products offered 270
11.1.2.3 Recent developments 274
11.1.2.3.1 Product launches/enhancements 274
11.1.2.3.2 Deals 274
11.1.2.4 MnM view 275
11.1.2.4.1 Key strengths 275
11.1.2.4.2 Strategic choices 275
11.1.2.4.3 Weaknesses and competitive threats 275
11.1.3 GAUMARD SCIENTIFIC 276
11.1.3.1 Business overview 276
11.1.3.2 Products offered 276
11.1.3.3 Recent developments 285
11.1.3.3.1 Product launches/enhancements 285
11.1.3.3.2 Deals 286
11.1.3.4 MnM view 286
11.1.3.4.1 Key strengths 286
11.1.3.4.2 Strategic choices 286
11.1.3.4.3 Weaknesses and competitive threats 286
11.1.4 KYOTO KAGAKU CO., LTD. 287
11.1.4.1 Business overview 287
11.1.4.2 Products offered 287
11.1.4.3 MnM view 293
11.1.4.3.1 Key strengths 293
11.1.4.3.2 Strategic choices 293
11.1.4.3.3 Weaknesses and competitive threats 293
11.1.5 LIMBS & THINGS LTD 294
11.1.5.1 Business overview 294
11.1.5.2 Products offered 294
11.1.5.3 Recent developments 298
11.1.5.3.1 Product launches/enhancements 298
11.1.5.3.2 Deals 298
11.1.5.4 MnM view 298
11.1.5.4.1 Key strengths 298
11.1.5.4.2 Strategic choices 299
11.1.5.4.3 Weaknesses and competitive threats 299
11.1.6 MENTICE AB 300
11.1.6.1 Business overview 300
11.1.6.2 Products offered 301
11.1.6.3 Recent developments 303
11.1.6.3.1 Product launches/enhancements 303
11.1.6.3.2 Deals 303
11.1.7 SIMULAB CORPORATION 305
11.1.7.1 Business overview 305
11.1.7.2 Products offered 305
11.1.7.3 Recent developments 312
11.1.7.3.1 Product launches/enhancements 312
11.1.8 SIMULAIDS 314
11.1.8.1 Business overview 314
11.1.8.2 Products offered 314
11.1.8.3 Recent developments 321
11.1.8.3.1 Product launches/enhancements 321
11.1.9 OPERATIVE EXPERIENCE, INC. 322
11.1.9.1 Business overview 322
11.1.9.2 Products offered 322
11.1.9.3 Recent developments 323
11.1.9.3.1 Developments 323
11.1.10 NASCO HEALTHCARE 324
11.1.10.1 Business overview 324
11.1.10.2 Products offered 324
11.1.10.3 Recent developments 325
11.1.10.3.1 Deals 325
11.1.11 ANATOMAGE 327
11.1.11.1 Business overview 327
11.1.11.2 Products offered 327
11.1.11.3 Recent developments 328
11.1.11.3.1 Product launches/enhancements 328
11.1.11.3.2 Other developments 329
11.1.12 CARDIONICS INC. 330
11.1.12.1 Business overview 330
11.1.12.2 Products offered 331
11.1.13 VIRTAMED AG 332
11.1.13.1 Business overview 332
11.1.13.2 Products offered 332
11.1.13.2.1 Product launches/enhancements 332
11.1.13.2.2 Deals 333
11.1.14 SYNBONE AG 334
11.1.14.1 Business overview 334
11.1.14.2 Products offered 334
11.1.15 INGMAR MEDICAL 336
11.1.15.1 Business overview 336
11.1.15.2 Products offered 336
11.1.15.3 Recent developments 337
11.1.15.3.1 Deals 337
11.1.16 MEDICAL-X 338
11.1.16.1 Business overview 338
11.1.16.2 Products offered 338
11.1.17 KAVO DENTAL 340
11.1.17.1 Business overview 340
11.1.17.2 Products offered 341
11.1.18 ALTAY SCIENTIFIC 342
11.1.18.1 Business overview 342
11.1.18.2 Products offered 342
11.1.19 TRUCORP LIMITED 347
11.1.19.1 Business overview 347
11.1.19.2 Products offered 347
11.1.19.3 Recent developments 348
11.1.19.3.1 Product launches/enhancements 348
11.1.19.3.2 Deals 349
11.1.20 SIMENDO 350
11.1.20.1 Business overview 350
11.1.20.2 Products offered 350
11.2 OTHER PLAYERS 351
11.2.1 HAAG-STREIT AG 351
11.2.2 SYMGERY 351
11.2.3 HRV SIMULATION 352
11.2.4 SYNAPTIVE MEDICAL 352
11.2.5 INOVUS LIMITED 353
12 APPENDIX 354
12.1 DISCUSSION GUIDE 354
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 360
12.3 CUSTOMIZATION OPTIONS 362
12.4 RELATED REPORTS 362
12.5 AUTHOR DETAILS 363
LIST OF TABLES
TABLE 1 EXCHANGE RATES CONSIDERED FOR CONVERTING CURRENCIES TO USD 32
TABLE 2 RISK ASSESSMENT: HEALTHCARE SIMULATION MARKET 47
TABLE 3 HEALTHCARE SIMULATION MARKET: PORTER’S FIVE FORCES ANALYSIS 70
TABLE 4 KEY PATENTS IN HEALTHCARE SIMULATION MARKET, 2022–2024 74
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 8 HEALTHCARE SIMULATION MARKET: REGULATORY STANDARDS 78
TABLE 9 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 79
TABLE 10 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 80
TABLE 11 NMPA MEDICAL DEVICE CLASSIFICATION 81
TABLE 12 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM 82
TABLE 13 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM 84
TABLE 14 PRICING RANGE OF HEALTHCARE SIMULATION PRODUCTS PROVIDED BY KEY PLAYERS, 2024 85
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 90
TABLE 16 KEY BUYING CRITERIA FOR TOP THREE END USERS 90
TABLE 17 UNMET NEEDS IN HEALTHCARE SIMULATION MARKET 92
TABLE 18 EXPECTATIONS OF END USERS OF HEALTHCARE SIMULATION SOLUTIONS 93
TABLE 19 TABLE 1: US-ADJUSTED RECIPROCAL TARIFF RATES 95
TABLE 20 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 100
TABLE 21 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2023–2030 (USD MILLION) 101
TABLE 22 HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY REGION,
2023–2030 (USD MILLION) 101
TABLE 23 KEY PLAYERS OFFERING PATIENT SIMULATORS 103
TABLE 24 PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 25 PATIENT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 104
TABLE 26 PATIENT SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 105
TABLE 27 KEY MARKET PLAYERS OFFERING HIGH-FIDELITY SIMULATORS 106
TABLE 28 HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 106
TABLE 29 KEY MARKET PLAYERS OFFERING MEDIUM-FIDELITY SIMULATORS 107
TABLE 30 MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 108
TABLE 31 KEY MARKET PLAYERS OFFERING LOW-FIDELITY SIMULATORS 109
TABLE 32 LOW-FIDELITY PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 33 LAPAROSCOPIC SURGICAL PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 34 GYNECOLOGY PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 35 CARDIOVASCULAR PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 36 ORTHOPEDIC SURGICAL PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 113
TABLE 37 SPINE SURGICAL PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 114
TABLE 38 ENDOVASCULAR PATIENT SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 39 PATIENT SIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 40 KEY MARKET PLAYERS OFFERING TASK TRAINERS 117
TABLE 41 TASK TRAINERS MARKET, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 42 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 43 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 119
TABLE 44 KEY MARKET PLAYERS OFFERING LAPAROSCOPIC SURGICAL SIMULATORS 120
TABLE 45 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 46 KEY MARKET PLAYERS OFFERING GYNECOLOGY SIMULATORS 121
TABLE 47 GYNECOLOGY SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 48 KEY MARKET PLAYERS OFFERING CARDIOVASCULAR SIMULATORS 122
TABLE 49 CARDIOVASCULAR SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 50 KEY MARKET PLAYERS OFFERING ORTHOPEDIC SIMULATORS 123
TABLE 51 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 52 KEY MARKET PLAYERS OFFERING SPINE SURGICAL SIMULATORS 125
TABLE 53 SPINE SURGICAL SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 54 KEY MARKET PLAYERS OFFERING ENDOVASCULAR SIMULATORS 126
TABLE 55 ENDOVASCULAR SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 56 KEY MARKET PLAYERS OFFERING OTHER SURGICAL SIMULATORS 128
TABLE 57 OTHER SURGICAL SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 58 KEY MARKET PLAYERS OFFERING ULTRASOUND SIMULATORS 129
TABLE 59 ULTRASOUND SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 60 KEY PLAYERS OFFERING DENTAL SIMULATORS 130
TABLE 61 DENTAL SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 62 KEY PLAYERS OFFERING EYE SIMULATORS 131
TABLE 63 EYE SIMULATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 131
TABLE 64 KEY PLAYERS OFFERING WEB-BASED SIMULATORS 132
TABLE 65 WEB-BASED SIMULATION MARKET, BY REGION, 2023–2030 (USD MILLION) 133
TABLE 66 KEY MARKET PLAYERS OFFERING HEALTHCARE SIMULATION SOFTWARE 133
TABLE 67 HEALTHCARE SIMULATION SOFTWARE MARKET, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 68 HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 69 HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 135
TABLE 70 KEY MARKET PLAYERS OFFERING VENDOR-BASED TRAINING SERVICES 136
TABLE 71 VENDOR-BASED TRAINING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 72 KEY PLAYERS OFFERING EDUCATIONAL SOCIETIES SIMULATORS 137
TABLE 73 EDUCATIONAL SOCIETIES MARKET, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 74 KEY MARKET PLAYERS OFFERING CUSTOM CONSULTING SERVICES 138
TABLE 75 CUSTOM CONSULTING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 138
TABLE 76 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 140
TABLE 77 VIRTUAL PATIENT SIMULATION MARKET, BY REGION, 2023–2030 (USD MILLION) 141
TABLE 78 3D PRINTING MARKET, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 79 PROCEDURAL REHEARSAL TECHNOLOGY MARKET, BY REGION,
2023–2030 (USD MILLION) 143
TABLE 80 HEALTHCARE SIMULATION MARKET, BY END USER, 2023–2030 (USD MILLION) 145
TABLE 81 HEALTHCARE SIMULATION MARKET IN ACADEMIC INSTITUTES, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 82 HEALTHCARE SIMULATION MARKET IN HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 83 HEALTHCARE SIMULATION MARKET IN MILITARY ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 84 HEALTHCARE SIMULATION MARKET IN OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 149
TABLE 85 HEALTHCARE SIMULATION MARKET, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 86 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 87 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 153
TABLE 88 NORTH AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 89 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 154
TABLE 90 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 155
TABLE 91 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 92 NORTH AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 93 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 156
TABLE 94 NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 156
TABLE 95 US: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 158
TABLE 96 US: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 97 US: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 98 US: PATIENT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159
TABLE 99 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 100 US: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 101 US: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 160
TABLE 102 US: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 103 CANADA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 161
TABLE 104 CANADA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 105 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 106 CANADA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 163
TABLE 107 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 108 CANADA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 109 CANADA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 164
TABLE 110 CANADA: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 164
TABLE 111 EUROPE: HEALTHCARE SIMULATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 166
TABLE 112 EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 166
TABLE 113 EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 114 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 115 EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 168
TABLE 116 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 117 EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 118 EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 169
TABLE 119 EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 120 UK: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 170
TABLE 121 UK: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 122 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 123 UK: PATIENT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172
TABLE 124 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 125 UK: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 173
TABLE 126 UK: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 173
TABLE 127 UK: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 173
TABLE 128 FRANCE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 174
TABLE 129 FRANCE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 130 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 131 FRANCE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 176
TABLE 132 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 176
TABLE 133 FRANCE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 134 FRANCE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 177
TABLE 135 FRANCE: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 177
TABLE 136 GERMANY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 178
TABLE 137 GERMANY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 138 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 139 GERMANY: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 180
TABLE 140 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 141 GERMANY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 142 GERMANY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 181
TABLE 143 GERMANY: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 181
TABLE 144 ITALY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 182
TABLE 145 ITALY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 146 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 147 ITALY: PATIENT SIMULATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184
TABLE 148 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 149 ITALY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 150 ITALY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 185
TABLE 151 ITALY: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 185
TABLE 152 SPAIN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 186
TABLE 153 SPAIN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 154 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 155 SPAIN: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 188
TABLE 156 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 188
TABLE 157 SPAIN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 158 SPAIN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 189
TABLE 159 SPAIN: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 189
TABLE 160 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 190
TABLE 161 REST OF EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 162 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 191
TABLE 163 REST OF EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 192
TABLE 164 REST OF EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 165 REST OF EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 166 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 193
TABLE 167 REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 168 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 196
TABLE 169 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 196
TABLE 170 ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 171 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 197
TABLE 172 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 198
TABLE 173 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 174 ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 175 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 199
TABLE 176 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 199
TABLE 177 JAPAN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 201
TABLE 178 JAPAN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 179 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 180 JAPAN: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 202
TABLE 181 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 182 JAPAN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 203
TABLE 183 JAPAN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 203
TABLE 184 JAPAN: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 203
TABLE 185 CHINA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 204
TABLE 186 CHINA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 187 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 188 CHINA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 206
TABLE 189 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 190 CHINA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 191 CHINA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 207
TABLE 192 CHINA: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 207
TABLE 193 INDIA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 208
TABLE 194 INDIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 195 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209
TABLE 196 INDIA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 210
TABLE 197 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 198 INDIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 199 INDIA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 211
TABLE 200 INDIA: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 211
TABLE 201 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 212
TABLE 202 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 203 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 204 REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 214
TABLE 205 REST OF ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 206 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 215
TABLE 207 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 215
TABLE 208 REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 215
TABLE 209 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 216
TABLE 210 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 216
TABLE 211 LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 212 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 217
TABLE 213 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 218
TABLE 214 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 218
TABLE 215 LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 219
TABLE 216 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 219
TABLE 217 LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 219
TABLE 218 BRAZIL: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 220
TABLE 219 BRAZIL: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 220 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 221 BRAZIL: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 222
TABLE 222 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 222
TABLE 223 BRAZIL: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 223
TABLE 224 BRAZIL: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 223
TABLE 225 BRAZIL: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 223
TABLE 226 MEXICO: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 224
TABLE 227 MEXICO: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 228 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 229 MEXICO: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 226
TABLE 230 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 226
TABLE 231 MEXICO: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 227
TABLE 232 MEXICO: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 227
TABLE 233 MEXICO: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 227
TABLE 234 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET,
BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 228
TABLE 235 REST OF LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228
TABLE 236 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 237 REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 229
TABLE 238 REST OF LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 239 REST OF LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 240 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 231
TABLE 241 REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2023–2030 (USD MILLION) 231
TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 232
TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 232
TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 245 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 246 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 234
TABLE 247 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 234
TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235
TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 235
TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2023–2030 (USD MILLION) 235
TABLE 251 GCC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2023–2030 (USD MILLION) 236
TABLE 252 GCC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 253 GCC: PATIENT SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 254 GCC: PATIENT SIMULATORS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 238
TABLE 255 GCC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 238
TABLE 256 GCC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 239
TABLE 257 GCC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 239
TABLE 258 GCC: HEALTHCARE SIMULATION MARKET, BY END USER,
2023–2030 (USD MILLION) 239
TABLE 259 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET,
BY PRODUCT & SERVICE, 2023–2030 (USD MILLION) 240
TABLE 260 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 261 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 262 REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 241
TABLE 263 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 264 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 265 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 243
TABLE 266 REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET,
BY END USER, 2023–2030 (USD MILLION) 243
TABLE 267 HEALTHCARE SIMULATION MARKET: OVERVIEW OF STRATEGIES ADOPTED
BY KEY PLAYERS, JANUARY 2022–MAY 2025 245
TABLE 268 HEALTHCARE SIMULATION MARKET: REGION FOOTPRINT 254
TABLE 269 HEALTHCARE SIMULATION MARKET: PRODUCT & SERVICE FOOTPRINT 255
TABLE 270 HEALTHCARE SIMULATION MARKET: END USER FOOTPRINT 256
TABLE 271 HEALTHCARE SIMULATION MARKET: TECHNOLOGY FOOTPRINT 257
TABLE 272 HEALTHCARE SIMULATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 260
TABLE 273 HEALTHCARE SIMULATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 261
TABLE 274 HEALTHCARE SIMULATION MARKET: PRODUCT LAUNCHES/ENHANCEMENTS, JANUARY 2022–MAY 2025 263
TABLE 275 HEALTHCARE SIMULATION MARKET: DEALS, JANUARY 2022–MAY 2025 264
TABLE 276 HEALTHCARE SIMULATION MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–MAY 2025 265
TABLE 277 SURGICAL SCIENCE SWEDEN AB: COMPANY OVERVIEW 266
TABLE 278 SURGICAL SCIENCE SWEDEN AB: PRODUCTS OFFERED 267
TABLE 279 SURGICAL SCIENCE SWEDEN AB: DEALS 268
TABLE 280 LAERDAL MEDICAL: COMPANY OVERVIEW 270
TABLE 281 LAERDAL MEDICAL: PRODUCTS OFFERED 270
TABLE 282 LAERDAL MEDICAL: PRODUCT LAUNCHES/ENHANCEMENTS 274
TABLE 283 LAERDAL MEDICAL: DEALS 274
TABLE 284 GAUMARD SCIENTIFIC: COMPANY OVERVIEW 276
TABLE 285 GAUMARD SCIENTIFIC: PRODUCTS OFFERED 276
TABLE 286 GAUMARD SCIENTIFIC: PRODUCT LAUNCHES/ENHANCEMENTS 285
TABLE 287 GAUMARD SCIENTIFIC CO.: DEALS 286
TABLE 288 KYOTO KAGAKU CO., LTD.: COMPANY OVERVIEW 287
TABLE 289 KYOTO KAGAKU CO., LTD.: PRODUCTS OFFERED 287
TABLE 290 LIMBS & THINGS LTD: COMPANY OVERVIEW 294
TABLE 291 LIMBS & THINGS LTD: PRODUCTS OFFERED 294
TABLE 292 LIMBS & THINGS LTD: PRODUCT LAUNCHES/ENHANCEMENTS 298
TABLE 293 LIMBS & THINGS LTD: DEALS 298
TABLE 294 MENTICE AB: COMPANY OVERVIEW 300
TABLE 295 MENTICE AB: PRODUCTS OFFERED 301
TABLE 296 MENTICE AB: PRODUCT LAUNCHES/ENHANCEMENTS 303
TABLE 297 MENTICE AB: DEALS, JANUARY 2022–MAY 2025 303
TABLE 298 SIMULAB CORPORATION: COMPANY OVERVIEW 305
TABLE 299 SIMULAB CORPORATION: PRODUCTS OFFERED 305
TABLE 300 SIMULAB CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS 312
TABLE 301 SIMULAIDS: COMPANY OVERVIEW 314
TABLE 302 SIMULAIDS: PRODUCTS OFFERED 314
TABLE 303 SIMULAIDS: PRODUCT LAUNCHES/ENHANCEMENTS 321
TABLE 304 OPERATIVE EXPERIENCE, INC.: COMPANY OVERVIEW 322
TABLE 305 OPERATIVE EXPERIENCE, INC.: PRODUCTS OFFERED 322
TABLE 306 OPERATIVE EXPERIENCE, INC.: DEVELOPMENTS 323
TABLE 307 NASCO HEALTHCARE: COMPANY OVERVIEW 324
TABLE 308 NASCO HEALTHCARE: PRODUCTS OFFERED 324
TABLE 309 NASCO HEALTHCARE: DEALS 325
TABLE 310 ANATOMAGE: COMPANY OVERVIEW 327
TABLE 311 ANATOMAGE: PRODUCTS OFFERED 327
TABLE 312 ANATOMAGE: PRODUCT LAUNCHES/ENHANCEMENTS 328
TABLE 313 ANATOMAGE: OTHER DEVELOPMENTS 329
TABLE 314 CARDIONICS INC.: COMPANY OVERVIEW 330
TABLE 315 CARDIONICS INC.: PRODUCTS OFFERED 331
TABLE 316 VIRTAMED AG: COMPANY OVERVIEW 332
TABLE 317 VIRTAMED AG: PRODUCTS OFFERED 332
TABLE 318 VIRTAMED AG: PRODUCT LAUNCHES/ENHANCEMENTS 332
TABLE 319 VIRTAMED AG: DEALS 333
TABLE 320 SYNBONE AG: COMPANY OVERVIEW 334
TABLE 321 SYNBONE AG: PRODUCTS OFFERED 334
TABLE 322 INGMAR MEDICAL: COMPANY OVERVIEW 336
TABLE 323 INGMAR MEDICAL: PRODUCTS OFFERED 336
TABLE 324 INGMAR MEDICAL: DEALS 337
TABLE 325 MEDICAL-X: COMPANY OVERVIEW 338
TABLE 326 MEDICAL-X: PRODUCTS OFFERED 338
TABLE 327 KAVO DENTAL: COMPANY OVERVIEW 340
TABLE 328 KAVO DENTAL: PRODUCTS OFFERED 341
TABLE 329 ALTAY SCIENTIFIC: COMPANY OVERVIEW 342
TABLE 330 ALTAY SCIENTIFIC: PRODUCTS OFFERED 342
TABLE 331 TRUCORP LIMITED: COMPANY OVERVIEW 347
TABLE 332 TRUCORP LIMITED: PRODUCTS OFFERED 347
TABLE 333 TRUCORP LIMITED: PRODUCT LAUNCHES/ENHANCEMENTS 348
TABLE 334 TRUCORP LIMITED: DEALS 349
TABLE 335 SIMENDO: COMPANY OVERVIEW 350
TABLE 336 SIMENDO: PRODUCTS OFFERED 350
LIST OF FIGURES
FIGURE 1 HEALTHCARE SIMULATION MARKET SEGMENTATION AND REGIONAL SCOPE 30
FIGURE 2 HEALTHCARE SIMULATION MARKET: RESEARCH DESIGN 34
FIGURE 3 PRIMARY SOURCES 36
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION,
AND REGION 38
FIGURE 5 ESTIMATION OF MARKET SIZE FOR HEALTHCARE SIMULATION ACADEMIC INSTITUTES AND HOSPITALS THROUGH DEMAND-SIDE APPROACH 40
FIGURE 6 ESTIMATION OF GLOBAL HEALTHCARE SIMULATION MARKET SIZE THROUGH DEMAND-SIDE APPROACH 41
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 8 BOTTOM-UP APPROACH: SEGMENTAL EXTRAPOLATION 42
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 43
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
FIGURE 11 DATA TRIANGULATION 45
FIGURE 12 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,
2025 VS. 2030 (USD MILLION) 48
FIGURE 13 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 49
FIGURE 14 HEALTHCARE SIMULATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50
FIGURE 15 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 51
FIGURE 16 GROWING DEMAND FOR MINIMALLY INVASIVE TREATMENTS TO DRIVE MARKET 52
FIGURE 17 HEALTHCARE SIMULATION ANATOMICAL MODELS SEGMENT AND CHINA ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024 53
FIGURE 18 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL HEALTHCARE SIMULATION MARKET DURING FORECAST PERIOD 54
FIGURE 19 NORTH AMERICA TO COMMAND HEALTHCARE SIMULATION MARKET THROUGHOUT FORECAST PERIOD 55
FIGURE 20 EMERGING COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 55
FIGURE 21 HEALTHCARE SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 56
FIGURE 22 TOP MINIMALLY INVASIVE COSMETIC PROCEDURES PERFORMED IN 2022 59
FIGURE 23 HEALTHCARE SIMULATION MARKET: ECOSYSTEM 68
FIGURE 24 HEALTHCARE SIMULATION MARKET: VALUE CHAIN ANALYSIS 70
FIGURE 25 PATENT PUBLICATION TRENDS (2015–2025) 72
FIGURE 26 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) OF HEALTHCARE SIMULATION PATENTS (JANUARY 2015–MAY 2025) 73
FIGURE 27 TOP APPLICANTS FOR HEALTHCARE SIMULATION PATENTS
(JANUARY 2015–MAY 2025) 74
FIGURE 28 INDICATIVE PRICE OF HEALTHCARE SIMULATION PRODUCTS,
BY KEY PLAYERS 2024 85
FIGURE 29 RECENT INVESTMENTS IN HEALTHCARE SIMULATION MARKET, 2022–2025 87
FIGURE 30 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 89
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 89
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 90
FIGURE 33 NORTH AMERICA: HEALTHCARE SIMULATION MARKET SNAPSHOT 152
FIGURE 34 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET SNAPSHOT 195
FIGURE 35 HEALTHCARE SIMULATION MARKET: REVENUE ANALYSIS OF TWO KEY PLAYERS, 2020–2024 247
FIGURE 36 MARKET SHARE ANALYSIS OF COMPANIES OFFERING HEALTHCARE SIMULATION PRODUCTS, 2024 248
FIGURE 37 HEALTHCARE SIMULATION MARKET RANKING ANALYSIS, 2024 249
FIGURE 38 HEALTHCARE SIMULATION MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 252
FIGURE 39 HEALTHCARE SIMULATION MARKET: COMPANY FOOTPRINT 253
FIGURE 40 HEALTHCARE SIMULATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 259
FIGURE 41 BRAND/SOFTWARE COMPARISON 262
FIGURE 42 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2024) 267
FIGURE 43 MENTICE AB: COMPANY SNAPSHOT (2024) 301
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11